1. Home
  2. ELTX vs SRBK Comparison

ELTX vs SRBK Comparison

Compare ELTX & SRBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ELTX
  • SRBK
  • Stock Information
  • Founded
  • ELTX 2011
  • SRBK 1887
  • Country
  • ELTX United States
  • SRBK United States
  • Employees
  • ELTX N/A
  • SRBK N/A
  • Industry
  • ELTX Biotechnology: Pharmaceutical Preparations
  • SRBK
  • Sector
  • ELTX Health Care
  • SRBK
  • Exchange
  • ELTX Nasdaq
  • SRBK Nasdaq
  • Market Cap
  • ELTX 158.5M
  • SRBK 117.2M
  • IPO Year
  • ELTX N/A
  • SRBK N/A
  • Fundamental
  • Price
  • ELTX $8.77
  • SRBK $15.21
  • Analyst Decision
  • ELTX Strong Buy
  • SRBK
  • Analyst Count
  • ELTX 1
  • SRBK 0
  • Target Price
  • ELTX $13.00
  • SRBK N/A
  • AVG Volume (30 Days)
  • ELTX 107.4K
  • SRBK 22.7K
  • Earning Date
  • ELTX 11-13-2025
  • SRBK 10-30-2025
  • Dividend Yield
  • ELTX N/A
  • SRBK 1.32%
  • EPS Growth
  • ELTX N/A
  • SRBK 374.69
  • EPS
  • ELTX N/A
  • SRBK 0.54
  • Revenue
  • ELTX N/A
  • SRBK $31,130,000.00
  • Revenue This Year
  • ELTX N/A
  • SRBK N/A
  • Revenue Next Year
  • ELTX N/A
  • SRBK N/A
  • P/E Ratio
  • ELTX N/A
  • SRBK $27.97
  • Revenue Growth
  • ELTX N/A
  • SRBK 0.85
  • 52 Week Low
  • ELTX $4.60
  • SRBK $10.75
  • 52 Week High
  • ELTX $12.62
  • SRBK $15.46
  • Technical
  • Relative Strength Index (RSI)
  • ELTX 34.58
  • SRBK 59.71
  • Support Level
  • ELTX $8.60
  • SRBK $14.60
  • Resistance Level
  • ELTX $9.49
  • SRBK $15.35
  • Average True Range (ATR)
  • ELTX 0.49
  • SRBK 0.19
  • MACD
  • ELTX 0.02
  • SRBK 0.05
  • Stochastic Oscillator
  • ELTX 14.10
  • SRBK 72.00

About ELTX Elicio Therapeutics Inc.

Elicio Therapeutics Inc is a clinical-stage biotechnology company pioneering the development of cancer immunotherapies for patients with limited treatment options and poor outcomes. Its proprietary Amphiphile, or AMP, platform delivers investigational immunotherapeutics directly to the brain center of the immune system the lymph nodes. Its focus is the development of cancer immunotherapies against biologically validated but hard-to-drug targets that can be activated through lymph node trafficking.

About SRBK SR Bancorp Inc. Common stock

SR Bancorp Inc principal business is to acquire deposits from individuals and businesses in the communities surrounding offices and to use these deposits to fund loans.

Share on Social Networks: